Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new build of the page and updating the version shown in the history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study record history now shows a new revision entry, v3.6.3, superseding the previous v3.6.2. This indicates an update to the record's content or metadata.SummaryDifference0.1%

- Check43 days agoChange Detected- The page's revision label updated from v3.6.0 to v3.6.2 in the record history. This change indicates a newer version of the page's history UI and does not alter the study data, eligibility, status, or presented content.SummaryDifference0.1%

- Check58 days agoChange DetectedRecruitment status updated to 'no longer looking for participants', indicating that the study is not enrolling currently. The record now shows Revision: v3.6.0, replacing the previous Revision: v3.5.5.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page's footer revision tag was updated from v3.5.4 to v3.5.5. This reflects a new release of the page's content without altering study data or core functionality.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 entry and indicating a minor update in the page's version history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.